BofA lowered the firm’s price target on RXO Inc. (RXO) to $15 from $17 and keeps a Neutral rating on the shares. Given pressure from weather-related demand impacts and above-seasonal spot market tightness, the firm lowered its Q1 adjusted EBITDA forecast to $5M from $9M, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: